IMXI - International Money Express, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.89
-0.38 (-4.59%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close8.27
Open8.27
Bid7.85 x 1200
Ask10.00 x 1000
Day's Range7.29 - 8.49
52 Week Range6.46 - 16.10
Volume111,546
Avg. Volume249,704
Market Cap300.091M
Beta (5Y Monthly)N/A
PE Ratio (TTM)15.17
EPS (TTM)0.52
Earnings DateMar 08, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.08
  • GlobeNewswire

    International Money Express, Inc. to Participate in Virtual Fireside Chat with BTIG

    MIAMI, March 23, 2020 -- International Money Express, Inc. (NASDAQ: IMXI), a leading money remittance services company focused primarily on the Latin America and Caribbean.

  • GlobeNewswire

    International Money Express, Inc. Provides COVID-19 Business Update

    International Money Express, Inc. (IMXI), a leading money remittance services company focused primarily on the Latin America and Caribbean corridor, today provided a business update regarding the ongoing impact of COVID-19. At International Money Express, the well-being of our customers and employees is at the center of everything we do. In response to the COVID-19 crisis, all of our United States based headquarters personnel have been empowered to work from home to protect themselves and their families.

  • INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Misses Q4 Earnings and Revenue Estimates
    Zacks

    INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Misses Q4 Earnings and Revenue Estimates

    INTERNATIONAL MONEY EXPRESS, INC. (IMXI) delivered earnings and revenue surprises of -9.09% and -0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    International Money Express, Inc. Announces Results for the Fourth Quarter and Full Year 2019; Introduces Guidance for Full Year 2020

    Fourth Quarter 2019 - Financial Highlights Revenues grew 10.9% versus the prior year period as industry volumes moderatedNet Income totaled $5.3 million, compared to $4.9.

  • ACCESSWIRE

    International Money Express, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 9, 2020 / International Money Express, Inc. (IMXI) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 9, 2020 at ...

  • Should Value Investors Buy INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Stock?
    Zacks

    Should Value Investors Buy INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks

    INTERNATIONAL MONEY EXPRESS, INC. (IMXI) Reports Next Week: Wall Street Expects Earnings Growth

    INTERNATIONAL MONEY EXPRESS, INC. (IMXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • If You Had Bought International Money Express (NASDAQ:IMXI) Stock A Year Ago, You'd Be Sitting On A 12% Loss, Today
    Simply Wall St.

    If You Had Bought International Money Express (NASDAQ:IMXI) Stock A Year Ago, You'd Be Sitting On A 12% Loss, Today

    The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...

  • GlobeNewswire

    International Money Express, Inc. to Release Fourth Quarter and Full Year 2019 Earnings on Monday, March 9, 2020

    MIAMI, Feb. 25, 2020 -- International Money Express, Inc. (NASDAQ: IMXI) will release fourth quarter and full year 2019 earnings after the close of trading on Monday, March 9,.

  • Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences
    Zacks

    Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences

    Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences

  • Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
    Zacks

    Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion

    Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion

  • 4 Top-Ranked Liquid Bets to Build a Successful Portfolio
    Zacks

    4 Top-Ranked Liquid Bets to Build a Successful Portfolio

    Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.

  • GlobeNewswire

    International Money Express, Inc. Announces Partnership with Ripple

    International Money Express, Inc. (IMXI), a leading money remittance services company focused primarily on the Latin America and Caribbean corridor, announced today that it has partnered with Ripple, a provider of leading enterprise blockchain solutions for global payments. The partnership will enable Intermex to utilize Ripple's On-Demand Liquidity (ODL) product, through RippleNet, the company’s global network of financial institutions that sends money globally, instantly and reliably for fractions of a penny. ODL leverages the digital asset XRP as a real-time bridge between the sending and receiving currencies, and alleviates the need for pre-funding accounts in cross border payments.

  • Is INTERNATIONAL MONEY EXPRESS, INC. (IMXI) a Great Value Stock Right Now?
    Zacks

    Is INTERNATIONAL MONEY EXPRESS, INC. (IMXI) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • GlobeNewswire

    International Money Express, Inc. Announces Hiring of Chief Information Officer

    International Money Express, Inc. (IMXI), a leading money remittance services company focused primarily on the Latin America and Caribbean corridor, today announced that Max Leiva has joined the company as its Chief Information Officer, reporting directly to Intermex COO Joseph Aguilar. Mr. Leiva joins the firm from SES, the world’s leading Satellite Company, where he was focused on building innovative digital Satellite solutions to create revenue growth in the U.S. and Latin American regions.

  • Zacks.com featured highlights include: Synaptics, MagnaChip Semiconductor, Tandem Diabetes Care and International Money Express
    Zacks

    Zacks.com featured highlights include: Synaptics, MagnaChip Semiconductor, Tandem Diabetes Care and International Money Express

    Zacks.com featured highlights include: Synaptics, MagnaChip Semiconductor, Tandem Diabetes Care and International Money Express

  • Check 4 Best Liquid Bets to Power Your Portfolio
    Zacks

    Check 4 Best Liquid Bets to Power Your Portfolio

    Four top-ranked liquid stocks that investors can bank on for fat returns.

  • Millennial's Pay-and-Go Trend to Push These 5 Stocks Higher
    Zacks

    Millennial's Pay-and-Go Trend to Push These 5 Stocks Higher

    Millennials are backing away from cash as innovations in the digital payments industry makes cashless transactions convenient and secure.

  • New Strong Buy Stocks for January 22nd
    Zacks

    New Strong Buy Stocks for January 22nd

    New Strong Buy Stocks for January 22nd

  • Global Payments (GPN) Soars to 52-Week High, Time to Cash Out?
    Zacks

    Global Payments (GPN) Soars to 52-Week High, Time to Cash Out?

    Global Payments (GPN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Hedge Funds Have Never Been This Bullish On International Money Express, Inc. (IMXI)
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On International Money Express, Inc. (IMXI)

    Is International Money Express, Inc. (NASDAQ:IMXI) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise […]

  • New Highs All Around on Delayed Reaction to Trade Deal
    Zacks

    New Highs All Around on Delayed Reaction to Trade Deal

    New Highs All Around on Delayed Reaction to Trade Deal

  • Shareholders Should Look Hard At International Money Express, Inc.’s (NASDAQ:IMXI) 1.7%Return On Capital
    Simply Wall St.

    Shareholders Should Look Hard At International Money Express, Inc.’s (NASDAQ:IMXI) 1.7%Return On Capital

    Today we'll evaluate International Money Express, Inc. (NASDAQ:IMXI) to determine whether it could have potential as...

  • 3 Small-Cap Stocks with Big-Time Upside Potential
    TipRanks

    3 Small-Cap Stocks with Big-Time Upside Potential

    It’s hard for the little guys to get noticed sometimes, but often, it’s the little guys that are worth watching. Naturally, this applies to investing, too.Much has been said already about the record-breaking year for the S&P 500. As we reached the final month of the decade, after such a sustained rally, it is getting harder and harder to find true bargains. The top analysts, though, know that further down the market cap ladder, unseen by the casual observer, is where some of the true gems reside, the ones from which investors stand to reap substantial rewards.So, we took out our virtual bargain detector, opened TipRanks’ Stock Screener and looked for 3 stocks with smaller market caps poised for growth, specifically ones the analysts think are set for gains in the months ahead. Let’s take a closer look.International Money Express (IMXI)Remittances are making an increasingly large impact on the economies of many countries, playing a part in their economic growth, and in people’s livelihoods. Overall global remittance is expected to grow 3.7% to $715 billion in 2019. This includes $549 billion to developing nations.One company hoping to get a slice of the growing industry is International Money Express. The Miami based company provides remittance services for select Latin American markets, with strongholds in the two biggest markets - it is the market leader in Guatemala, and the second largest provider in Mexico.Additionally, IMXI has set its sights on new territories, both in Latin America and Africa, as well as expanding in the US and Canada. The company favors a differentiated agent acquisition strategy of handpicking agents with which the local migrant population has a cultural or linguistic affinity over increasing the number of agent locations.Cowen’s George Mihalos thinks the game plan is working well. The 5-star analyst noted, “We believe IMXI deserves a premium valuation relative to its money remittance peers given its superior growth profile and differentiated business model [..] We see IMXI leveraging its differentiated agent strategy to further capture market share in the Latin American remittance corridor, driving sustainable low-mid teens revenue growth. With the shares trading at a discount to slower growing peers such as WU, we see an opportunity for multiple expansion near term.”To this end, Mihalos initiated coverage on IMX stock with an Outperform rating, along with a price target of $17. This conveys the 5-star analyst’s confidence in IMXI’s ability to climb 32% higher in the next 12 months. (To watch Mihalos’ track record, click here)Where does the rest of the Street side on this digital payments platform? It appears mostly bullish, as TipRanks analytics demonstrate IMXI as a Strong Buy. Out of 5 analysts tracked by TipRanks in the last 3 months, 4 are bullish on the stock while 1 remains sidelined. With a return potential of nearly 36%, the stock’s consensus target price stands at $17.50 (See IMXI stock analysis on TipRanks)Exicure (XCUR)With a market cap of $219.6 million, Exicure is the smallest company on our list. The micro-cap biotech focuses on developing drugs for neurology, oncology, and dermatology.Exicure’s unique selling point (USP) is its proprietary spherical nucleic acid (SNA) technology, which can better the delivery and efficiency of current nucleic acid-based therapies. The company is expected to announce its first SNA based neurology candidate before year’s end, and it has indicated it will be a rare indication for which there are few available therapies. In addition, Exicure also recently announced an agreement with Allergan to develop treatments for hair disorders, also based on Exicure’s SNA technology.The pioneering biotech has excited Guggenheim’s Yatin Suneja, who wrote, “We expect XCUR’s SNA platform to attract interest from biopharma companies. We believe that nucleic acid therapeutics are a growing class of products, and the highly adaptive SNA technology could potentially improve the delivery and efficiency of multiple compounds. Therefore, we expect strong interest (as highlighted by a recent collaboration with Allergan) from various biopharma players in partnering with XCUR to leverage this technology.”As a result, Suneja thinks the stock, currently at $2.89, will soon be worth $9.00 a share, and recommends buying it. We are talking about over 200% upside here. (To watch Suneja’s track record, click here)Suneja’s bullish call resonates with the Street. Although only 3 analysts have weighed in with a view on Exicure over the last 3 months, all have rated the biotech pioneer as a Buy, making the Street consensus a Strong Buy. The average target stands at $7.33, below Suneja’s target, but still providing ample upside of 154%. (See Exicure stock analysis on TipRanks)Teladoc (TDOC)The advent of the smartphone has changed the way we interact with the world in every possible way, from shopping, to how we get around, to how we consume culture, amongst many other novelties. One industry going through a smart technological transformation right now is the health industry, with the rise of the telehealth space disrupting traditional doctor-patient conventions.RBC’s Sean Dodge thinks Teledoc is ‘virtually unstoppable,’ noting, “Virtual health is going mainstream. Awareness and comfort with the technology is reaching a tipping point and the breadth of potential use-cases is expanding rapidly. There are more examples of this surfacing across healthcare every day. We are also seeing increasing evidence Virtual First benefit design is beginning to take hold, which adds even more momentum to our outlook. While the rising tide will lift all boats, we believe Teladoc is the best positioned to capitalize on this. It's superior consumer engagement platform, breadth of offerings/clinical capabilities and global reach are all important and durable competitive differentiators. The combination of new member adds, cross-selling and ramping utilization should continue to drive 25%+ organic revenue growth for the next 3+ years..”On the back of the glowing assessment, Dodge initiated coverage on Teladoc stock, with an Outperform rating. The analyst suggests that if everything goes as planned, TDOC will be a $100 stock in the next 12 months, implying nearly 28% return. (To watch Dodge’s track record, click here)To find other good ideas for cannabis stocks trading at fair value or better, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.